Abpro Holdings Inc. (NASDAQ:ABP – Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling 18,253 shares, a growth of 271.4% from the January 15th total of 4,914 shares. Based on an average daily volume of 53,854 shares, the short-interest ratio is currently 0.3 days. Approximately 0.8% of the company’s stock are sold short. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 53,854 shares, the short-interest ratio is currently 0.3 days.
Abpro Price Performance
Shares of Abpro stock opened at $1.67 on Wednesday. Abpro has a 1-year low of $1.44 and a 1-year high of $34.65. The stock’s 50 day simple moving average is $3.90 and its 200-day simple moving average is $5.66. The stock has a market cap of $4.54 million, a P/E ratio of -0.39 and a beta of 0.01.
Abpro (NASDAQ:ABP – Get Free Report) last announced its earnings results on Friday, November 14th. The company reported ($0.63) earnings per share for the quarter, topping the consensus estimate of ($1.20) by $0.57.
Wall Street Analysts Forecast Growth
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Goldman Sachs Group Inc. bought a new stake in Abpro in the first quarter worth about $30,000. Geode Capital Management LLC grew its stake in shares of Abpro by 127.6% in the 2nd quarter. Geode Capital Management LLC now owns 196,494 shares of the company’s stock worth $42,000 after purchasing an additional 110,159 shares during the last quarter. Finally, Yorkville Advisors Global LP bought a new stake in shares of Abpro in the 3rd quarter worth approximately $192,000. Institutional investors and hedge funds own 23.30% of the company’s stock.
About Abpro
Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.
Read More
- Five stocks we like better than Abpro
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Abpro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abpro and related companies with MarketBeat.com's FREE daily email newsletter.
